MAP2K7 and neuroblastoma: To get insights into the underlying mechanisms of resistance to the MEK inhibitor AZD6244, we selected 6 neuroblastoma cells lines that represented the spectrum of sensitivity to MEK inhibition (sensitive: CHP212, LAN6; resistant: SKNAS, SKNSH, KELLY and IMR32).